stockportfolio.pro
Indivior Pharmaceuticals, Inc. Gross Profit 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual gross profit by fiscal year, computed from SEC filings. Compound growth +9.9%/yr over 3 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $994.00M | 80.2% | +3.9% |
| FY 2024 | $957.00M | 80.6% | +4.1% |
| FY 2023 | $919.00M | 84.1% | +22.7% |
| FY 2022 | $749.00M | 83.1% | — |
Source: Indivior Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Indivior Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIndivior Pharmaceuticals, Inc. — frequently asked questions
What is Indivior Pharmaceuticals, Inc.'s gross profit?
Indivior Pharmaceuticals, Inc. (INDV) reported gross profit of $994.00M for fiscal year 2025, per its SEC filings.
How has Indivior Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2022 and 2025, INDV's gross profit grew at roughly 9.9% per year (compound annual rate), from $749.00M to $994.00M.
Where does this data come from?
Figures are computed from Indivior Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.